The company said the new group will provide solutions for researchers in the fields of computational biology, genomics, proteomics, pharmacogenomics, pharmacogenetics, cheminformatics, medical informatics, and rational drug design.
The company said the new group will provide solutions for researchers in the fields of computational biology, genomics, proteomics, pharmacogenomics, pharmacogenetics, cheminformatics, medical informatics, and rational drug design.